Dog /
FDA CVM · 2025 release 52 reports on file

Alaskan Klee Kai - FDA Adverse Event Profile

Adverse-event records for Alaskan Klee Kai (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 6 4.5 3 1.5 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Alaskan Klee Kai drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

Among dog breeds, Alaskan Klee Kai is #269 by FDA report volume; 1.9% of its 52 reports (1) were death-coded.

#269
most-reported dog breed
1.9%
death-coded report share
13
Vomiting - top reaction
4.8 yr
average age at report

Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.

Total Reports

52

FDA CVM filings

Deaths Reported

1

of 52 reports

Death Rate

1.9%

death-coded share

Avg Age at Report

4.8 yr

9.9 kg avg weight

Death-Coded Outcome Share

Alaskan Klee Kai death-coded reports 1.9%
Cross-breed median

1.9% of 52 alaskan klee kai reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 9.9 kg (21.8 lbs)

Top Reported Reactions

Vomiting 13
Emesis 6
Lethargy (see also Central nervous system depression in 'Neurological') 6
Emesis (multiple) 5
Diarrhoea 5

Most Referenced Drugs

Milbemycin Oxime + Spinosad 21
Fluralaner 13.64% 12-Week Chew 5
Spinosad 4
Ivermectin + Pyrantel As Pamoate Salt 3
Milbemycin Oxime + Praziquantel 3

Outcome Breakdown

Recovered/Normal
27 (51.9%)
Outcome Unknown
16 (30.8%)
Ongoing
8 (15.4%)
Died
1 (1.9%)

Gender Distribution

Female 28 (53.8%)
Male 23 (44.2%)
Unknown 1 (1.9%)

Reports by Year

Year Reports Trend
2013 1
2014 7
2015 5
2016 3
2017 5
2018 1
2019 5
2020 3
2021 5
2022 4
2023 6
2024 5
2025 2

Alaskan Klee Kai Pet Health Insights

Alaskan Klee Kai accounts for 52 FDA adverse event reports, ranking #269 by volume among dog breeds, with 1 reports (1.9%) coded as a death outcome. Mean age at report: 4.8 years, average weight 9.9 kg (21.8 lbs).

Top reported signs: Vomiting (13), Emesis (6), Lethargy (see also Central nervous system depression in 'Neurological') (6). Most-referenced drug: Milbemycin Oxime + Spinosad (21 reports), followed by Fluralaner 13.64% 12-Week Chew (5) and Spinosad (4).

Outcome coding on 52 status-recorded reports is dominated by Recovered/Normal (51.9%). Annual submissions ranged 2,013-2,025 across 13 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Alaskan Klee Kai?
There are 52 adverse event reports involving Alaskan Klee Kai in the FDA database, with 1 reports involving death (1.9% death rate). Alaskan Klee Kai ranks #269 by report volume.
What are the most common adverse reactions reported for Alaskan Klee Kai?
The most commonly reported adverse reactions for Alaskan Klee Kai are Vomiting (13 reports), Emesis (6 reports), Lethargy (see also Central nervous system depression in 'Neurological') (6 reports), Emesis (multiple) (5 reports), Diarrhoea (5 reports).
What drugs are most frequently associated with Alaskan Klee Kai adverse events?
The drugs most frequently referenced in Alaskan Klee Kai adverse event reports are Milbemycin Oxime + Spinosad (21 reports), Fluralaner 13.64% 12-Week Chew (5 reports), Spinosad (4 reports), Ivermectin + Pyrantel As Pamoate Salt (3 reports), Milbemycin Oxime + Praziquantel (3 reports).
What is the average age of Alaskan Klee Kai in adverse event reports?
The average age of Alaskan Klee Kai at the time of adverse event reports is 4.8 years, with an average weight of 9.9 kg (21.8 lbs).
Does a high number of adverse event reports mean Alaskan Klee Kai is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Alaskan Klee Kai safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.